https://www.indianpharmapost.com/kims-invests-further-in-sarvejana-healthcare-135602023-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-approval-from-usfda-for-fesoterodine-fumarate-extended-release-tablets-135612023-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/dabur-india-expects-low-to-mid-single-digit-revenue-growth-for-q3-fy23-135622023-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-launches-topiramate-extended-release-capsules-135632023-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-receives-usfda-final-approval-for-fesoterodine-fumarate-extended-release-tablets-135642023-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/anssi-wellness-inaugurates-new-spine-health-facility-in-nashik-135652023-01-07T00:00:00+05:30always0.9